Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Healy

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Science Translational Medicine|September 10, 2025
Type I interferon limits central nervous system autoimmunity by modulating the microRNA-21-FOXO1 axis in pathogenic T helper 17 cellsJohnna Francis Varghese, Mai Fujiwara, Amrendra K Ajay, et al.
Plos Genetics|January 3, 2009
IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor productionLisa M Maier, Christopher E Lowe, Jason Cooper, et al.
Medrxiv : the Preprint Server for Health Sciences|July 14, 2025
Nasal foralumab treatment of PIRA induces regulatory immunity, dampens microglial activation and stabilizes clinical progression in non-active secondary progressive MSTanuja Chitnis, Tarun Singhal, Jonathan Zurawski, et al.
NEJM Evidence|May 30, 2024
Intranasal Oxytocin for ObesityFranziska Plessow, Liya Kerem, Marie-Louis Wronski, et al.
JAMA Neurology|March 3, 2025
Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-AnalysisGillian T Coughlan, Hannah M Klinger, Rory Boyle, et al.
Annals of Clinical and Translational Neurology|September 18, 2025
A Multi-Center Retrospective Cohort Study of Neurosarcoidosis Myelitis: Current Observations and Future DirectionsGiovanna S Manzano, Denis Balaban, Yihan Zhang, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
The prognostic value of blood-based p-tau217 levels on progression to clinical impairmentRachel F Buckley, Diana L Townsend, Colin J Birkenbihl, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Science Translational Medicine|September 10, 2025
Type I interferon limits central nervous system autoimmunity by modulating the microRNA-21-FOXO1 axis in pathogenic T helper 17 cellsJohnna Francis Varghese, Mai Fujiwara, Amrendra K Ajay, et al.
Plos Genetics|January 3, 2009
IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor productionLisa M Maier, Christopher E Lowe, Jason Cooper, et al.
Medrxiv : the Preprint Server for Health Sciences|July 14, 2025
Nasal foralumab treatment of PIRA induces regulatory immunity, dampens microglial activation and stabilizes clinical progression in non-active secondary progressive MSTanuja Chitnis, Tarun Singhal, Jonathan Zurawski, et al.
NEJM Evidence|May 30, 2024
Intranasal Oxytocin for ObesityFranziska Plessow, Liya Kerem, Marie-Louis Wronski, et al.
JAMA Neurology|March 3, 2025
Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-AnalysisGillian T Coughlan, Hannah M Klinger, Rory Boyle, et al.
Annals of Clinical and Translational Neurology|September 18, 2025
A Multi-Center Retrospective Cohort Study of Neurosarcoidosis Myelitis: Current Observations and Future DirectionsGiovanna S Manzano, Denis Balaban, Yihan Zhang, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
The prognostic value of blood-based p-tau217 levels on progression to clinical impairmentRachel F Buckley, Diana L Townsend, Colin J Birkenbihl, et al.
Pageof 6